Naloxone use by Aotearoa New Zealand emergency medical services, 2017–2021
Emergency Medicine Australasia · 2024
DOI: 10.1111/1742-6723.14358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emergency Medicine Australasia, 2024. Verfasst von Eeva-Katri Kumpula und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Poisons Centre, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Naloxone, Emergency Medical Services, Narcotic Antagonists. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Emergency medical services (EMS) use of naloxone in the prehospital setting is indicated in patients who have significantly impaired breathing or level of consciousness when opioid intoxication is suspected. The present study characterised naloxone use in a nationwide sample of Aotearoa New Zealand road EMS patients to establish a baseline for surveillance of any changes in the future.
Methods
A retrospective analysis of rates of patients with naloxone administrations was conducted using Hato Hone St John (2017–2021) and Wellington Free Ambulance (2018–2021) electronic patient report form datasets. Patient demographics, presenting complaints, naloxone dosing, and initial and last vital sign clinical observations were described.
Results
There were 2018 patients with an equal proportion of males and females, and patient median age was 47 years. There were between 8.0 (in 2018) and 9.0 (in 2020) naloxone administrations per 100 000 population‐years, or approximately one administration per day for the whole country of 5 million people. Poisoning by unknown agent(s) was the most common presenting complaint (61%). The median dose of naloxone per patient was 0.4 mg; 85% was administered intravenously. The median observed change in Glasgow Coma Scale score was +1, and respiratory rate increased by +2 breaths/min.
Conclusions
A national rate of EMS naloxone patients was established; measured clinical effects of naloxone were modest, suggesting many patients had reasons other than opioid toxicity contributing to their symptoms. Naloxone administration rates provide indirect surveillance information about suspected harmful opioid exposures but need to be interpreted with care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Poisons Centre, University of Otago, Dunedin, New Zealand.
- Hato Hone St John, Auckland, New Zealand.
- Paramedicine Research Unit, Paramedicine Department, Auckland University of Technology, Auckland, New Zealand.
- Te Whatu Ora Hutt Hospital, Lower Hutt, New Zealand.
- Wellington Free Ambulance, Wellington, New Zealand.
ORCID-Profile: Eeva-Katri Kumpula, Verity F Todd, Bridget L Dicker, Adam C Pomerleau
Zitieren
APA
Kumpula, E. K., Todd, V. F., O'Byrne, D., Dicker, B. L., & Pomerleau, A. C. (2024). Naloxone use by Aotearoa New Zealand emergency medical services, 2017–2021. Emergency Medicine Australasia. https://doi.org/10.1111/1742-6723.14358
Vancouver
Kumpula EK, Todd VF, O'Byrne D, Dicker BL, Pomerleau AC. Naloxone use by Aotearoa New Zealand emergency medical services, 2017–2021. Emergency Medicine Australasia. 2024. doi:10.1111/1742-6723.14358
BibTeX
@article{Kumpula2024,
author = {Kumpula, Eeva-Katri and Todd, Verity F and O'Byrne, David and Dicker, Bridget L and Pomerleau, Adam C},
title = {Naloxone use by Aotearoa New Zealand emergency medical services, 2017–2021},
journal = {Emergency Medicine Australasia},
year = {2024},
doi = {10.1111/1742-6723.14358}
}
EUVIMED